Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-02-26 Exercise | 2021-03-01 4:15 pm | N/A 2029-11-13 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 2,000 | $0 | 105,508 (Direct) | View |
| 2021-02-26 Exercise | 2021-03-01 4:15 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 2,000 | $2.62 | 105,508 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-15 4:30 pm | N/A 2029-11-13 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 2,000 | $0 | 105,508 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-15 4:30 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 2,000 | $2.62 | 105,508 (Direct) | View |
| 2020-12-22 Exercise | 2020-12-23 4:15 pm | N/A 2029-11-13 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 4,000 | $0 | 105,508 (Direct) | View |
| 2020-12-22 Exercise | 2020-12-23 4:15 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 4,000 | $2.62 | 105,508 (Direct) | View |
| 2020-08-06 Option Award | 2020-08-10 6:01 pm | N/A 2030-08-05 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 141,226 | $0 | 141,226 (Direct) | View |
Ownership | 2020-08-06 9:09 pm | N/A 2029-11-13 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 0 | $0 | 105,508 (Direct) | View |